A dibenzochrysene-based type i photosensitizer and a preparation method and application thereof
By designing a Type I photosensitizer based on dibenzo-rich ene, the problems of strong oxygen dependence and poor photodynamic effect of existing photosensitizers with xanthones were solved, and a high-yield, low-cytotoxic near-infrared photosensitizer was prepared, which is suitable for fluorescence imaging and photodynamic therapy.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SICHUAN UNIV
- Filing Date
- 2024-01-04
- Publication Date
- 2026-06-02
AI Technical Summary
Existing type I photosensitizers are highly oxygen-dependent, resulting in incomplete efficacy of photodynamic therapy in hypoxic tumor environments. Furthermore, existing zeatin nucleus compounds have poor photodynamic effects.
A Type I photosensitizer based on dibenzo-fullen was designed and synthesized via a Buchwald-Hartwig coupling reaction. The photosensitizer with a dibenzo-fullen structure was controlled by the molar ratio of 3,6-dibromofluorenone, alkyl or aryl amine, ligand, palladium catalyst, and basic substance. The synthesis conditions were mild and the yield was high.
The prepared photosensitizer has a long fluorescence emission and a large Stokes shift, avoids background spectral crosstalk, possesses Type I photodynamic potential, near-infrared emission characteristics, low cytotoxicity, and is suitable for fluorescence imaging and photodynamic therapy.
Smart Images

Figure CN117865860B_ABST